Science Explorer Back to mapMap
Discussion
Nonprofit · Mainz · Germany

Boehringer Ingelheim Fonds

Research works
2
▲ 390% vs 2018-21
Citations
92
44.4 per fractional work
Top-10% rate
0.0%
all institutions 10.0%
Open access
27%
world 40%
International
61%
world 18%

Not ranked overall: Boehringer Ingelheim Fonds is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Boehringer Ingelheim Fonds work in?

In all years, 62% of research at Boehringer Ingelheim Fonds is in Life Sciences, 19% in Physical Sciences. Its largest fields are Neuroscience (29%), Biochemistry, Genetics and Molecular Biology (24%), Chemistry (19%). It does 1.3× the world's share of Life Sciences.

Life Sciences62%Physical Sciences19%Health Sciences19%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 5 fields, with their numbers
    1. Neuroscience128.6%
    2. Biochemistry, Genetics and Molecular Biology023.8%
    3. Immunology and Microbiology09.5%
    1. Chemistry019.0%
    1. Medicine019.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from Boehringer Ingelheim Fonds?

The most cited paper from Boehringer Ingelheim Fonds is "Cloning of TRAP, a ligand for CD40 on human T cells" (Daniel Graf, Ulf Korthäuer, Hans Werner Mages et al., 1992), with 283 citations. Next come "Comparison of Characteristics and Outcomes of Dabigatran Versus Warfarin in Hypertensive Patients With Atrial Fibrillation (from the RE-LY Trial)" (62) and "Active intermixing of indirect and direct neurons builds the striatal mosaic" (52).

Most cited papers
#PaperReleasedCitations
1 Cloning of TRAP, a ligand for CD40 on human T cells Daniel Graf, Ulf Korthäuer, Hans Werner Mages et al. · European Journal of Immunology Dec 1992 283
2 Comparison of Characteristics and Outcomes of Dabigatran Versus Warfarin in Hypertensive Patients With Atrial Fibrillation (from the RE-LY Trial) Rangadham Nagarakanti, Lars C. Wallentin, Herbert Noack et al. · The American Journal of Cardiology 28 Jul 2015 62
3 Active intermixing of indirect and direct neurons builds the striatal mosaic Andrea Tinterri, Fabien Ménardy, Marco A. Diana et al. · Nature Communications Open access 5 Nov 2018 52
4 Calcium-requirement for activation of skinned vascular smooth muscle from spontaneously hypertensive (SHRSP) and normotensive control rats U. Mrwa, Konrad Güth, C. Haist et al. · Life Sciences 1986 34
5 Tangential migration of corridor guidepost neurons contributes to anxiety circuits Andrea Tinterri, Marie Deck, Maryama Keita et al. · The Journal of Comparative Neurology Open access 18 Sep 2017 14
All 8 most cited papers, with filters and sorting

Which research topics does Boehringer Ingelheim Fonds publish most on?

By volume in 2022-now: Chemical Synthesis and Analysis, Analytical Chemistry and Chromatography, Functional Brain Connectivity Studies and Neurogenesis and neuroplasticity mechanisms.

  1. 1 Chemical Synthesis and Analysis Molecular Biology 0 works
  2. 2 Analytical Chemistry and Chromatography Spectroscopy 0 works
  3. 3 Functional Brain Connectivity Studies Cognitive Neuroscience 0 works
  4. 4 Neurogenesis and neuroplasticity mechanisms Developmental Neuroscience 0 works
  5. 5 Neurotransmitter Receptor Influence on Behavior Cellular and Molecular Neuroscience 0 works
  6. 6 Neurological disorders and treatments Neurology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available26.6%not open73.4%

World: 40% of research is openly available.

with international co-authors61.2%domestic only38.8%

World: 18% is written across borders.

How has Boehringer Ingelheim Fonds's research output changed?

Output in 2022-2025 was 390% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Mainz

All research institutions in Mainz

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Boehringer Ingelheim Fonds. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.